- Home
- WGS vs SRPT Comparison
WGS vs SRPT Comparison
Compare WGS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGS
- SRPT
- Stock Information
- Founded
- WGS 2017
- SRPT 1980
- Country
- WGS United States
- SRPT United States
- Employees
- WGS N/A
- SRPT N/A
- Industry
- WGS Retail: Computer Software & Peripheral Equipment
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- WGS Technology
- SRPT Health Care
- Exchange
- WGS Nasdaq
- SRPT Nasdaq
- Market Cap
- WGS 2.4B
- SRPT 1.9B
- IPO Year
- WGS N/A
- SRPT 1997
- Fundamental
- Price
- WGS $166.40
- SRPT $21.03
- Analyst Decision
- WGS Strong Buy
- SRPT Hold
- Analyst Count
- WGS 8
- SRPT 28
- Target Price
- WGS $130.63
- SRPT $26.00
- AVG Volume (30 Days)
- WGS 536.5K
- SRPT 6.2M
- Earning Date
- WGS 10-28-2025
- SRPT 11-03-2025
- Dividend Yield
- WGS N/A
- SRPT N/A
- EPS Growth
- WGS N/A
- SRPT N/A
- EPS
- WGS 0.07
- SRPT N/A
- Revenue
- WGS $402,190,000.00
- SRPT $2,413,715,000.00
- Revenue This Year
- WGS $39.54
- SRPT $10.20
- Revenue Next Year
- WGS $22.50
- SRPT N/A
- P/E Ratio
- WGS $2,298.07
- SRPT N/A
- Revenue Growth
- WGS 50.50
- SRPT 47.15
- 52 Week Low
- WGS $55.17
- SRPT $10.42
- 52 Week High
- WGS $170.75
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- WGS 74.87
- SRPT 56.90
- Support Level
- WGS $119.43
- SRPT $15.94
- Resistance Level
- WGS $147.71
- SRPT $20.15
- Average True Range (ATR)
- WGS 9.54
- SRPT 1.32
- MACD
- WGS 3.23
- SRPT 0.31
- Stochastic Oscillator
- WGS 92.28
- SRPT 97.88
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.